A breaking news podcast from ASCO GU in San Francisco! Prof Louise Emmett (St Vincent's, Sydney), has just read out the latest update from the ENZA-P trial (and simultaneous publication in Lancet Oncology), reporting that the combination of LuPSMA and enzalutamide improves overall survival when compared with enzalutamide alone, in men with poor prognosis mCRPC. Big news!!

We celebrate the start of the Paris 2024 Olympics with our own Prostate Cancer Olympics! This is a Themed Podcast supported by our Gold Partners, Johnson & Johnson